Prevalence of Methicillin-Resistant Staphylococcus aureus Colonization and Infection in Hospitalized Palliative Care Patients With Cancer

Abstract

Little is known about the pattern of methicillin-resistant Staphylococcus aureus (MRSA) colonization and infection in hospitalized palliative care (PC) patients. We reviewed 854 admissions for 289 patients with advanced cancer managed by a PC service in a tertiary care hospital. The MRSA screening was performed at least once in 228 (79%) patients, and 21 (9%) of them were MRSA positive. Other cultures were done in 251 (86.8%) patients, and 8 (3%) patients were MRSA positive. The total number of MRSA-positive admissions was 28 (3%), with a median admission duration of 8 days. A substantial proportion of hospitalized PC patients with cancer are MRSA positive. Research is required to study the impact of infection control measures on the quality of PC delivered to MRSA-positive terminally ill patients in hospitals.

Keywords

infection control hospital-based palliative care advanced cancer prevalence quality of life

Get full access to this article

View all access options for this article.

References

World Health Organization. WHO Global Strategy for Containment of Antimicrobial Resistance. Geneva: World Health Organization; 2001.

Morgan

Diekema

Sepkowitz

Perencevich

. Adverse outcomes associated with contact precautions: a review of the literature. Am J Infect Control. 2009;37(2):85–93.

Bükki

Klein

But

. Methicillin-resistant Staphylococcus aureus (MRSA) management in palliative care units and hospices in Germany: a nationwide survey on patient isolation policies and quality of life [published online November 1, 2011]. Palliat Med. 2011.

Prentice

Dunlop

Armes

Cunningham

Lucas

Todd

. Methicillin-resistant Staphylococcus aureus infection in palliative care. Palliat Med. 1998;12(6):443–449.

Ali

Sykes

Flock

Hall

Buchan

. An investigation of MRSA infection in a hospice. Palliat Med. 2005;19(3):188–196.

Thompson

Silveira

Vitale

Malani

. Antimicrobial use at the end of life among hospitalized patients with advanced cancer [published online January 4, 2012]. Am J Hosp Palliat Care. 2012.